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Abstract
Background: Cadmium is one of the inflammation-related xenobiotics and has been regarded as
a potent carcinogen. The relationship between inflammation and cell proliferation due to chronic
infection has been studied, but the mechanism is not fully clear. Though the mode of cadmium
toxicity is well characterized in animal cells, still it requires some further investigations. Previously
we reported that cadmium induces immune cell death in Swiss albino mice. In the present study we
showed that instead of inducing cell death mechanism, cadmium in low concentration triggers
proliferation in mice lung cell and our results reveals that prior to the induction of proliferation it
causes severe inflammation.
Methods: Swiss albino mice were treated with different concentrations of cadmium to determine
the LD50. Mice were subdivided (5 mice each) according to the exposure period (15, 30, 45, 60
days) and were given sub lethal dose (5 mg/Kg body weight) of cadmium chloride and ibuprofen (50
mg/Kg body weight, recommended dose) once in a week. SEM and histology were performed as
evidence of changes in cellular morphology. Inflammation was measured by the expression of Cox-
2 and MMPs. Expression of proinflammatory cytokines (Cox-2, IL-6), signaling and cell cycle
regulatory molecules (STAT3, Akt, CyclinD1) were measured by western blot, ELISA and
immunoprecipitation. Mutagenecity was evidenced by comet assay. Cell proliferation was
determined by cell count, cell cycle and DNA analysis.
Results:  Prolonged exposure of low concentration of cadmium resulted in up regulation of
proinflammatory cytokines and cell cycle regulatory molecules. Though NSAIDs like Ibuprofen
reduces the expression of inflammatory cytokines, but it did not show any inhibitory effect on
cadmium adopted lung cell proliferation.
Conclusion: Our results prove that cadmium causes both inflammation and cell proliferation
when applied in a low dose but proliferative changes occur independent of inflammation.
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Background
Cadmium has been shown to have various detrimental
effects on health [1]. Upon absorption, Cadmium is rap-
idly transported by blood to different organs in the body
where its estimated half-life in humans is 15–20 years [2].
Additionally chronic exposure to Cadmium has been
associated with a number of physiological consequences
such as renal failure and immunosuppression as well as
various types of cancers in mammals. Several toxicities
such as hepatoxicity, neurotoxicity and cardiotoxicity are
also documented under high Cadmium exposure [3,4]. In
recent years progress has been made in dissecting apart the
molecular mechanisms underlying the effects of exposure
to this toxic metal.
The amount of Cadmium absorbed in the body following
its exposure varies depending on the route of entry.
Though the primary routes of cadmium exposure in
humans are via inhalation from such sources as cigarette
smoking [5], food is also reported as source for human
exposure to Cadmium. Cadmium is selectively taken up
by certain edible plants and certain food items, such as
crab contains Cadmium as high as 30–50 ppm [6]. In gen-
eral, exposure of cells to low, micromolar concentrations
of Cadmium results significant toxicity [7,8]. Strong evi-
dence, based on experimental studies exists to support the
carcinogenic potential of Cadmium. Following various
routes of exposure to Cadmium, experimental animals
produce tumors of multiple organs [9,10]. Only about 5%
of a given dosage of cadmium is absorbed from the gas-
trointestinal tract, while lung absorption is as much as
90% of a dose inhaled into the lungs. Despite being one
of the major routes for cadmium absorption, the toxic
mechanism of cadmium on lung tissue is still poorly
understood [11].
Cadmium induced lung injuries have been recently iden-
tified which indicates that it provokes lung damage and
inflammation [12] by involving cytokine production [13].
Cadmium-adapted alveolar epithelial cells are protected
from oxidant-induced apoptosis along [14] with the
expression of the numerous genes in acute-phase proteins
or inflammatory cytokines [15]. The acquired self toler-
ance to Cadmium is thought to have some basis in toxi-
cokinetics but primarily concerns with modified tissue
responses [16]. Cadmium is one of the inflammation-
related xenobiotics and its exposure on the tissues is often
accompanied with infiltration of inflammatory cells [17].
Interleukin, such as IL-6 has a key role in the proliferation
of lung cell [18] and Cox-2 is an inducible inflammatory
enzyme plays an important role in the progression of
human lung adenocarcinoma [19]. Although Cox-2
expression in tumors increases angiogenesis, which is
highly associated with induction of various growth factors
like IL-6 [20]. Various studies reported that cadmium pro-
motes lung cell proliferation by an immune suppressive
network which involves over expression of Cox-2 [21]. On
the other hand IL-6 and its receptor interactions activate
STAT3 which in turn induce the expression of several anti
apoptotic proteins and thereby promotes cell prolifera-
tion. It is reported that cell expresses elevated levels of
CyclinD1 when stably transfected with a dominant-active
STAT3 construct [22]. Therefore the general mode of
action of all these signaling molecules are either directly
related to the inflammation only or to the development of
cell proliferation influenced by chronic inflammation.
Although cadmium exposure has been reported to cause
neoplastic transformation of human prostatic epithelial
cells, but the efficacy of this transformation is highly
dependent on the dose of the metal ion [23,24]. Exposure
of normal human prostate epithelial cells to higher dose
(10 μM) cadmium transiently increased the expression of
p53, c-myc, and c-jun after 2 hr as a prelude to apoptosis
[25] where as lower dose promotes proliferation and
resistance to apoptosis.
We are particularly interested in the contribution of low
doses (5 mg/kg body weight) of cadmium to the transfor-
mation of mice lung. We have found that, due to cad-
mium exposure, expression of IL-6, STAT3 and
inflammatory enzyme MMP-2, Cox-2 increased signifi-
cantly. Also we have the evidences that increased activity
of the Akt signaling axis in lung cells appears to operate in
conjunction with or parallel to increased STAT3 activation
to induce proliferation programme. We showed that cad-
mium promotes lung inflammation and cell proliferation
both in independent manner. Thus, this study was
designed to determine the effects of chronic exposures of
low concentration of Cadmium in vivo. It is not worthy
that anti-inflammatory drug treatment could not totally




Antibodies against Cyclooxigenase-2 (Cox-2), IL-6, STAT-
3, p-STAT3, Akt, p-Akt, CyclinD1, β-actin and anti-mouse-
AP, anti-rabbit AP antibodies was obtained from Cell Sig-
naling Technology, Inc. USA. Prestain molecular weight
protein marker and standard DNA ladder, goat anti
mouse-HRP and anti rabbit-HRP conjugated antibody
and DAB developing system for immunohistochemistry
were purchased from Bangalore Genei (India). Gelatin
substrate for MMP was purchased from Sigma USA. Ibu-
profen and the remaining chemicals were purchased from
local firms (India) and were of highest purity grade.
Animal models and treatment
All animal experiments were performed following "Princi-
ples of laboratory animal care" (NIH publication No. 85-Journal of Inflammation 2009, 6:19 http://www.journal-inflammation.com/content/6/1/19
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23, revised in 1985) as well as specific Indian laws on
"Protection of Animals" under the provision of author-
ized investigators. Swiss albino mice (~25 g each; 5 mice
in each group) were randomly divided into three groups
such as (i) Control set, (ii) Cadmium (5 mg/Kg body
weight) treated set, (iii) Cadmium and Ibuprofen (50 mg/
Kg body weight) treated set. These sets were again divided
into four groups according to the time dependent expo-
sure (like 15 days, 30 days, 45 days, 60 days) of Cadmium
and Ibuprofen. Cadmium chloride and Ibuprofen were
dissolved in sterile pyrogen-free saline water and were
given as i.p injection. Control set were given sterile pyro-
gen-free saline water only as i.p [26].
Histological analysis
Lungs were taken after treatment and were washed in PBS
immediately. The tissues were fixed for 24 hours in buff-
ered formaldehyde solution (10% in PBS) at room tem-
perature, dehydrated by graded ethanol and embedded in
Paraffin (MERCK, Solidification point 60–62°C, TEST
CAS No-8002-74-2). Tissue sections (thickness 5 μm)
were deparaffinized with xylene, stained with eosin/hae-
matoxylin, Digital images were captured with Olympus
CAMEDIA digital camera, Model C-7070 wide zoom
(100×) [27].
Preparation of Cytosol
Lung were homogenized in homogenizing buffer (0.25 M
sucrose, 5 mM HEPES buffer, and 1 mM EDTA, pH 7.2),
containing protease inhibitor PMSF (SRL, India). The
homogenate was centrifuged at 500 × g to pellet nuclei
and the resulting supernatant was centrifuged at 100,000
× g (29,000 rpm) for 60 min at 4°C in a 50.2 Ti rotar.
Cytosolic supernatant was collected and aliquots were fro-
zen by immersion in liquid nitrogen. It was stored at -
80°C until use.
Zymographic Analysis of MMP Activity
Cytosolic extracts of lungs were prepared and protein con-
centration was determined by Bradford method. Gelati-
nase zymography was performed in 10% NOVEX Pre-Cast
SDS Polyacrylamide Gel (Invitrogen Corp.) in the pres-
ence of 0.1% gelatin under non reducing conditions. Pro-
tein lysate of lungs were mixed with sample buffer and
loaded for SDS-PAGE with tris glycine SDS buffer as sug-
gested by the manufacturer (Novex). Samples were not
boiled before electrophoresis. Following electrophoresis
the gels were washed twice in 2.5% Triton X-100 for 30
min at room temperature to remove SDS. The gels were
then incubated at 37°C overnight in substrate buffer con-
taining 50 mM Tris-HCl and 10 mM CaCl2 at pH 8.0 and
stained with 0.5% Coomassie Blue R250 in 50% metha-
nol and 10% glacial acetic acid for 30 min and destained.
Upon renaturation of the enzyme, the gelatinases digest
the gelatin in the gel and give clear bands against an
intensely stained background. Protein standards were run
concurrently and approximate molecular weights were
determined by plotting the relative mobilities of known
proteins. After destaining, the bands were quantified
using the UVTtech software (GAS 9500/9511, SRL No-
0710161, Cambridge) [28].
ELISA
Lungs were dissected out after the stimulation of 5 mg/Kg
body weight Cadmium for two months and were homog-
enized in homogenizing buffer, and then supernatants
were collected and stored at -80°C. Cox-2 and IL-6 in the
supernatants were measured by ELISA according to the
manufacturers' instructions (Cell Signaling manual).
Immunohistochemistry
Sections (5 μm) were cut from paraffin embeddedtissues
and mounted on positively charged Super frost slides
(Export Mengel CF). Tissues were deparaffinized, rehy-
drated through graded alcohols, and then blocked for
endogenous peroxidase in 3% hydrogen peroxide in
methanol. All tissues were preblocked in Tris-buffered
saline containing 0.3% Triton, and 0.5% blocking agent
(BSA, SRL, India, and batch No-832095) and incubated
with Cox-2 (Cell signaling Technologies, USA), primary
antibody (1:30) overnight at 4°C for positive control.
Antisera specific for Cox-2 were diluted 1:30 in Tris-buff-
ered saline containing 0.3% Triton, and 0.5% blocking
agent. Immunoreactive complexes were detected using
DAB system (Bangalore GeNei DAB system, Cat #SFE5).
Slides were counterstained briefly in haematoxylin
(MERCK), mounted in DPX (MERCK). Slides for negative
control were treated with no primary antibody.
Western blot analysis
For western blot analysis of IL-6, p-Akt, Cox-2, p-STAT3
and CyclinD1, cell lysate was loaded into a 10%–15%
SDS-polyacrylamide gel. After electrophoresis the gel was
transferred to nitrocellulose membrane and blocked with
nonfat dry milk in TBS containing Tween-20. Each pri-
mary antibody was diluted at 1:1000 ratio in TBS and after
overnight incubation, the membrane was again blocked
with nonfat dry milk in TBS containing Tween-20. Sec-
ondary antibody was diluted at 1:1000 ratio and after 2
hours incubation the membrane was developed by NBT/
BCIP (HIMEDIA, Cat# RM 578, RM 2577). β-actin was
chosen for constitutive expression.
Immunoprecipitation
For immunoprecipitation, cleared lysate was prepared
and about 100 μg of protein were immunoprecipitated
using 10 μl of anti-cdk4 (Cell signaling Technologies,
USA) for overnight at 4°C with gentle rotation. 25 μl Pro-
tein G CL-Agarose (Bangalore Genei, India, Cat # LIA 43S)
was added to the previous mixture, depending on theJournal of Inflammation 2009, 6:19 http://www.journal-inflammation.com/content/6/1/19
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experiment and allowed it to mix for 4 hours at 4°C with
gentle rotation. It was then centrifuged at 3000 rpm for 2
min. The immunoprecipitates were washed extensively
with sterile PBS and separated by SDS-PAGE, followed by
western analyses with anti CyclinD1 antibody (Cell sign-
aling Technologies, USA) as described above.
Isolation of the lung cell & cell viability assay
Lung was removed from mice aseptically followed by
addition of collaginase. Single cell suspensions were made
in RPMI 1640 by passing the cell population through a
nylon mesh with 50 μm pore size. The leukocyte popula-
tion was then allowed to adhere in Petri dishes at 37° for
1 hour. The non-adherent cell populations were collected
and subjected to Ficoll-Hypaque density gradient separa-
tion. The buffy layer was collected, washed and used as the
source of cells. Viable lung cells were counted in haemo-
cytometer by trypan blue exclusion test and used for fur-
ther analysis.
Comet assay
Comet assays were performed under alkaline conditions
to determine the amount of double-strand DNA breaks.
Lungs from the mice treated with different concentrations
of Cadmium chloride were trypsinized and washed in PBS
before being added to preheated (37°C) low-melting
point agarose. The solution was pipetted onto slides pre-
coated with 1% agarose. The chilled slides were allowed to
lyse for 40 min at 4°C in 2.5 M NaCl, 100 mM NaEDTA
(pH 10), 10 mM Tris Base, 1% SDS, 1% Triton X-100 prior
to immersion in alkaline electrophoresis solution (300
mM NaOH, 1 mM EDTA, pH 13). After 30 min, slides
were placed into a horizontal electrophoresis chamber
samples for 30 min (1 V/cm at 4°C). The slides were
washed with deionized H2O to remove the alkaline
buffer, dehydrated in 70% ice-cold EtOH and air-dried
overnight. Slides were stained with EtBr (50 μg/ml) and
examined by microscopy (Lica, China). Tail length (TL)
was used to quantify the DNA damage. Image analysis
and quantification has been performed with Motic Image
software.
Scanning Electron microscopy
Lungs from normal, Cadmium treated (5 mg/Kg body
weight) and Cadmium plus Ibuprofen treated (50 mg/Kg
body weight) were dissected out from the mice and were
immediately washed into the phosphate buffer saline
(PBS) to remove any mucus, blood or any other contami-
nant. Tissues were fixed with 2.5% glutaraldehyde in 0.1
M phosphate buffer pH 7.2–7.4 for 24 hours. Tissues were
then dehydrated with graded Acetone (MERCK) (50%–
100%, 20 minutes each). We did not perform the Critical
point drying (CPD) step as the lung tissues were very frag-
ile. Sample were cut into small part and placed on the stab
and put into the IB-2 ion coater for gold coating. After
coating the sample were observed by S530-Hitachi SEM
instrument (Department of USIC, University of Burd-
wan).
Cell cycle analysis by flowcytometry
Lung cells were fixed with p-formaldehyde, permeabilized
with Triton X-100, and nuclear DNA was labeled with
propidium iodide (PI). Cell cycle phase distribution of
nuclear DNA was determined on FACS (Fluorescence-
Activated Cell Sorter) having fluorescence detector
equipped with 488 nm argon laser light source and 623
nm band pass filter (linear scale) using Cell Questpro soft-
ware (Becton Dickinson). Total 10,000 events were
acquired and flowcytrometric data were analyzed using
Cell Questpro software.
DNA analysis
For DNA laddering assay, lungs were first placed into liq-
uid nitrogen for immediate hardening. It was crushed
then into powder and followed the extraction protocol as
described in Molecular Cloning, Vol-1, Sambrook, Russell
(Chapter-6, Unit-6.4).
Statistical Analysis
Values are shown as Standard error of mean, except where
otherwise indicated. Data were analyzed and, when
appropriate, significance of the differences between mean
values was determined by the Student-T test. Results were
considered significant at p < 0.05.
Results
Determination of LD50 and dose for experiments
To determine the LD50, mice were administered different
concentration of Cadmium (2.5, 5, 10, 20, 40 and 80 mg/
Kg body weight) till 60 days period (single dose in a
week). It was found that 50% of the experimental popula-
tion died at a concentration of about 10 mg/Kg body
weights, (Fig. 1) and there is a significant decrease (p <
0.05) of survival according to the increasement of dose.
Therefore 5 mg/Kg body weight (sub lethal dose) concen-
tration was chosen for further experiments to elaborate
the intricate mechanisms.
Prolonged exposure of low dose of Cadmium induces lung 
oedema and inflammation
To evaluate the effect of low concentration of Cadmium
on mice lung cell, we pulsed the mice with 5 mg/kg body
weight Cadmium for different time interval subsequently
for 15 days, 30 days, 45 days, and 60 days. No lung lesion
or oedema was shown to develop upto 45 day. Histologi-
cal analysis revealed that appearance of alveolar oedema
and inflammation after prolonged cadmium exposure
along with the airspace enlargement after 8 -week of cad-
mium exposure (Fig. 2B). At the same time, mice those
who were exposed to same dose of cadmium chlorideJournal of Inflammation 2009, 6:19 http://www.journal-inflammation.com/content/6/1/19
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along with non steroidal anti-inflammatory drug like Ibu-
profen (50 mg/kg body weight), showed reduced level of
inflammatory development (Fig. 2C) while compared to
the normal (Fig. 2A). This data suggests that cadmium if
applied even in a very low concentration for a long period
of time can induce inflammation in experimental ani-
mals.
Zymography proves MMP-2 but not MMP-9 is one of the 
mediators of such type of inflammation
There are different mechanisms are thought to be respon-
sible for the development and progression of cadmium
induced inflammation in lung. Increased secretion and/or
activity of matrix metalloproteinases (MMP), especially
MMP-2 and MMP-9, have been identified in inflamma-
tory cells and tissues isolated from human suffering from
COPD [29]. In order to find out the mechanism of cad-
mium induced lung inflammation we performed the
zymograph analysis to measure the matrix metalloprotei-
nase expression. We observed significant expression of
MMP-2 but not MMP-9 (Fig. 3) throughout the experi-
mental period. Though NSAID like Ibuprofen is sufficient
enough in suppressing the expression of matrix metallo-
proteinases, but it failed to operate its inhibitory action
here, p < 0.05 with respect to the control.
Cyclooxygenase-2, IL-6, p-STAT3 and p-Akt expression are 
the key regulators of cadmium induced lung inflammation
The regulation of Cox-2 is very important in various
inflammatory and proliferative responses, which is some-
time induced by IL-6 [20] signaling pathway. Therefore,
we wanted to see that whether this cadmium induced lung
cell proliferation has any relationship with Cox-2 and IL-
6 expression and we found that expression of both Cox-2
and IL-6 were increased to a significant level while appli-
cation of Ibuprofen was able to reduce the expression of
Dose dependence survival of Cadmium treatment Figure 1
Dose dependence survival of Cadmium treatment. Each value represents the percentage of died populations in each 
dose chosen with +/- SEM (n = 5) and p < 0.05, compared to normal. The experimental groups represent the Cadmium treated 
mice [inject CdCl2, (i.p.)] at a concentration of 2.5 mg/Kg body weight, 5 mg/Kg body weight, 10 mg/Kg body weight, 20 mg/Kg 
body weight and 40 mg/Kg body weight and 80 mg/Kg body weight respectively. The sub lethal concentration (5 mg/Kg body 
weight) was chosen as an applied dose.Journal of Inflammation 2009, 6:19 http://www.journal-inflammation.com/content/6/1/19
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Cox-2 and IL-6 (Fig. 4A) and it was strongly supported by
our ELISA results (Fig. 4C). STAT3 and Akt are the down-
stream modulators of the IL-6 and there regulations are
important in growth signaling. So we studied the expres-
sion of p-STAT3 and p-Akt, following cadmium exposure.
In our study, we also observed, that both p-STAT3 and p-
Akt expression (but not the normal STAT3 and Akt) were
up regulated (Fig. 4A) in treated mice, but application of
Ibuprofen could not revert these expression status. The
result indicated that cadmium induced cell proliferation
through p-STAT3 and p-Akt activation may have inflam-
mation independent pathways. The investigation still
under progress (data not shown). Data is representative of
three independent experiments (p < 0.05).
Immunohistochemical expression of Cox-2
To support our previous result we observed the expression
level of Cox-2 by immunohistochemistry. After two
months of exposure cadmium treated lung showed
increased level of Cox-2 expression (Fig. 5B), and was
reduced in Ibuprofen treated lung (Fig. 5C), while com-
pared with the control slide (Fig. 5A). In negative control
set, no such expression of Cox-2 was observed (Fig. 5D,
5E, 5F). We observed same result in case of IL-6 expression
(data not shown). The result proved that low dose of cad-
mium causes inflammation of lung cell by inducing the
proinflammatory cytokine like Cox-2 and IL-6.
Low-dose Cadmium exposure increased cell number
So far we have proved that Cadmium, when applied in a
low concentration (Sub-lethal dose), capable of inducing
Histopathology of lung sections of Swiss albino exposed to Cadmium (5 mg/Kg body weight) showing progressive lung inflam- mation and prevention by Ibuprofen Figure 2
Histopathology of lung sections of Swiss albino exposed to Cadmium (5 mg/Kg body weight) showing progres-
sive lung inflammation and prevention by Ibuprofen. A, Histology of lung sections of normal mice. B, Mice were treated 
with low dose of Cadmium (5 mg/Kg body weight), subsequently for 15, 30, 45, 60 days, granulation and air space enlargement 
was shown after 45 days which is the sign of inflammatory development. C, Application of Ibuprofen reduces the chance of lung 
oedema formation throughout the experimental periods. Original magnification (100×).Journal of Inflammation 2009, 6:19 http://www.journal-inflammation.com/content/6/1/19
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SDS-PAGE and Gelatin zymography represent the expression of MMP-2 Figure 3
SDS-PAGE and Gelatin zymography represent the expression of MMP-2. Detection, by gelatin zymography, of 
matrix metalloproteinase-2 (MMP-2) and (MMP-9) expression at different time points after the induction of Cadmium (5 mg/Kg 
body weight). Lung cell extracts were prepared at days of 15, 30, 45 and 60 from normal (N), Cadmium treated and Cadmium 
plus Ibuprofen treated (three individual animals per dose) mice. The zymography was developed and stained as described in 
Materials and Methods. The picture shows increased expression of MMP-2(72 kD), which was not inhibited by Ibuprofen. Gel 
is representative of three comparable experiments indicate p < 0.05 with respect to the control.
Cadmium induced expression of Cox-2, IL-6, p-STAT3 and p-Akt Figure 4
Cadmium induced expression of Cox-2, IL-6, p-STAT3 and p-Akt. Cell lysate from control and treatment lung were 
subjected to western blot analysis and ELISA. A, Expression of Cox-2, IL-6, p-STAT3, p-Akt were increased throughout all the 
experimental period. Though Ibuprofen reduced the expression of Cox-2 and IL-6, but it could not be able to revert the 
expression of p-STAT3 and p-Akt. B, Bar graphs represent the quantitative densitometric value of the expressed protein. C, 
OD values showed significant increasement of Cox-2 and IL-6 expression by ELISA. Data is representative of three comparable 
experiments and indicate p < 0.05 with respect to the control.Journal of Inflammation 2009, 6:19 http://www.journal-inflammation.com/content/6/1/19
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the expression of some proteins, those are very much
involved in stimulating cellular inflammation and prolif-
eration. Therefore, we took the lung cell count after the
exposure of different concentrations of Cadmium. We
found that cell number increased in mice those were
adapted with low dose of Cadmium (5 mg/Kg body
weight), but at the same time reduced cell count were fol-
lowed in mice treated with high dose of Cadmium (10
mg, 20 mg, 40 mg and 80 mg/Kg body weight), when
compared with the normal (Fig. 6). This data clearly indi-
cates that chronic cadmium exposure first induced inflam-
mation and then cell proliferation. Data is representative
of three independent experiments (p < 0.05).
Immunohistochemical expression of Cox-2 Figure 5
Immunohistochemical expression of Cox-2. A, Control lung shows no expression of Cox-2. B, Cox-2 expression was 
profoundly increased in treated lung. C, Application of Ibuprofen reduces the expression level of Cox-2. D, E, F, Negative 
staining shows no such expression. Original magnification (100×).Journal of Inflammation 2009, 6:19 http://www.journal-inflammation.com/content/6/1/19
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DNA damage analysis clearly suggests that cellular effect 
of cadmium is totally dose dependent
For further confirmation of our cell count data, we per-
formed single cell gel electrophoresis (Comet assay), and
found that low exposure of Cadmium (5 mg/kg body
weight) did not show any significant DNA damage. We
performed the assay also with high dose (80 mg/kg body
weight) of Cadmium, to see whether it shows the same
effect or not. We observed that 80 mg/kg body weight
Cadmium induces tail formation, which was the indica-
tion of DNA damage. The result proved dual role of cad-
mium chloride, when applied in low dose it causes cell
proliferation, otherwise it promotes cell death (Fig. 7A). It
is clear from the Fig. 7B and Fig. 7C, that tail formation
and cellular deformity were increased along with the
application of high CdCl2 concentration. Data is repre-
sentative of three independent experiments (p < 0.05).
Evaluation of cell cycle pattern after cadmium treatment
We next studied the cell cycle phase distribution of lung
cells treated with Cadmium (5 mg/Kg body weight) for
two months (Fig. 8). It is interestingly seen that the results
supported our notion and the total DNA content of S-G2/
M phase in treated (Fig. 8B) group increased by 31.91%
compared to that of 11.40% in normal one (Fig. 8A). To
further confirm this data, we examined the DNA ladder-
ing pattern of the treated lung and compared it with the
control set. It is clear from the Fig. 8C that no the ladder
Cadmium causes lung cell proliferation Figure 6
Cadmium causes lung cell proliferation. We evaluated the effect of cadmium on the lung cell count in normal and treated 
mice. The normal and treated mice were given pyrogen free saline water and different dose of Cadmium (2.5 mg, 5 mg, 10 mg, 
20 mg, 40 mg and 80 mg/Kg body weight) respectively for two months. Cell count gradually increased in low dose of CdCl2 
(2.5, 5 mg/Kg body weight), but beyond that (10 mg, 20 mg, 40 mg and 80 mg/Kg body weight) cell death occurred. Data is rep-
resentative of three independent experiments (p < 0.05).Journal of Inflammation 2009, 6:19 http://www.journal-inflammation.com/content/6/1/19
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was formed in the low cadmium chloride treated lung,
which can be correlated with our cell count data and it
strongly suggests that Cadmium (low dose) itself by pro-
moting inflammatory responses can produce cellular pro-
liferation in mice lung, which could not be reverted by
non steroidal anti-inflammatory drug like Ibuprofen
(data not shown). Data is representative of three inde-
pendent experiments (p < 0.05).
Scanning Electron Microscopy
Our cell count and cell cycle results clearly indicated the
instead of inducing cell death mechanism cadmium in
low concentration promotes cell proliferation. We
observed the surface structure of lung after 60 days by
scanning electron microscopy to see whether there is any
formation of tumor likes growth or not. We did not
observe any tumor pattern on cell surface (Fig. 9A), but
architectural distortion of the pulmonary microvascula-
ture was evidenced in treated mice. Alveolar space was get-
ting narrow along with the enlargement epithelial
basement (Fig. 9B), which is the indication of acute
inflammation. In higher magnification, cell surface
became uneven and lobular (Fig. 9C), Narrow edicular
spaces signify the increasement of cell density (Fig. 9D).
Ibuprofen showed no effect to revert the structural
deformity of lung caused by cadmium.
Cadmium Induced CyclinD1 Regulation in lung Cell
Our previous experiment has proved that Cadmium (5
mg/Kg body weight) challenged lung cell acquired the
capacity of proliferation after a chronic exposure. Our cell
cycle pattern has revealed that cell number is increased
significantly in S and G2/M phase along with the reduc-
tion in G0/G1 phase, which is a clear indication of cell pro-
liferation. Therefore, we had to determine the expression
of any regulator, which is very much related with this
phage (S and G2/M) of cell cycle. We know that CyclinD1
can promote both G0/G1/S and S/G2/M progression [30].
Our western blot data shows that expression of CyclinD1
is increased in treated mice (Fig. 10A), for further confir-
mation we immunoprecipitated the cell lysate first with
Cdk4 antibody, and the performed SDS-PAGE with anti
CyclinD1 antibody, Fig. 10C indicated the complex for-
mation of Cdk4-CyclinD1 which was an evidence of cell
Comet assay Figure 7
Comet assay. A, DNA tail formation was increased in higher dose of Cadmium, while no significant change was observed 
between control and low dose. B, C, Showed tail formation increased significantly in 80 mg/Kg body weight dose of Cadmium. 
Data is representative of three independent experiments (p < 0.05).Journal of Inflammation 2009, 6:19 http://www.journal-inflammation.com/content/6/1/19
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cycle progression. Data is representative of three inde-
pendent experiments (p < 0.05).
Discussion
In this study we tried to reveal the mechanistic details of
Cadmium induced inflammation and proliferation in
lung. An association between the development of cancer
and inflammation has long been appreciated [31]. The
chronic inflammatory states associated with infection and
irritation may lead to environments that foster genomic
lesions and tumor initiation [32]. The results of the
present study showed that chronic exposure of cadmium
compound induces lung cell proliferation which may be
independent of lung inflammation. We hypothesized that
cadmium exposure induces the inflammatory cytokines
along with the cell proliferating factors in the lungs of
mice.
We found that cadmium causes cell death at high concen-
tration but at low level it is capable of inducing prolifera-
tion. Evidences are there indicate that low dose of
cadmium can induce neoplastic transformation of human
prostate epithelial cells [33]. Lung epithelial cells of cad-
mium treated (5 mg/Kg body weight) mice exhibits ele-
Effect of Cadmium on cell cycle distribution of mice lung cell determined by flowcytometry analysis Figure 8
Effect of Cadmium on cell cycle distribution of mice lung cell determined by flowcytometry analysis. B, Percent-
age of cell increased in S-G2/M phase in treated set. A, Increased cell number was observed in sub-G0/G1 phase in control set, 
which was the indication of cell proliferation. Data is representative of three independent experiments (p < 0.05).C, No DNA 
ladder was formed in low dose (5 mg/Kg body weight) CdCl2 treated lung while compared with control ladder (L) and normal 
one.Journal of Inflammation 2009, 6:19 http://www.journal-inflammation.com/content/6/1/19
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vated level of cellular proliferation along with the
accumulation of inflammatory molecules and cytokines.
Therefore, in search of the mechanism behind it we found
that cadmium induced the cellular signals to shift towards
the proliferation as a whole, but prior to the development
of cell proliferation cadmium initiated sever lung inflam-
mation. There is a supportive evidence that, lung cell is
able to become gradually resistant in response to cad-
mium [34]. We observed that IL-6 and inducible inflam-
matory enzyme Cox-2 elevated significantly in cadmium
exposed mice. We also observed the expression level of
TNFα, IL-1β, Hsp70, in cadmium treated lung cell (data
not shown), but we did not find any significant change in
their expression. That is why we mainly focused to see the
role of cadmium on influencing the cellular expression of
Cox-2, IL-6 and their down stream mediators, because of
the fact that along with inflammation, these are the two
known parameters of tumor development. Currently,
Cox-2 inhibitors are being assessed in clinical trials for
chemoprevention and as an adjuvant for conventional
therapy in lung cancer [35]. Additionally, anti-IL-6 ther-
apy has shown promising results in metastatic condition
[36]. In the current study, we showed that elevated IL-6
and Cox-2 expression could be reduced by non steroidal
anti-inflammatory drug like Ibuprofen. But at the same
time molecular mechanisms of their regulation remains
Scanning Electron Microscopy of Cadmium treated lung Figure 9
Scanning Electron Microscopy of Cadmium treated lung. A, No lobular appearances were observed under lower mag-
nification. B, Alveolar space was getting narrowed in treated lung, compared to the normal one. C, Lobular appearances were 
prominent at higher magnification. D, Narrow edicular spaces signify the increasement of cell density. Ibuprofen showed no 
effect to revert the structural deformity.Journal of Inflammation 2009, 6:19 http://www.journal-inflammation.com/content/6/1/19
Page 13 of 15
(page number not for citation purposes)
under observation (Data not shown here). Morphological
differences between lungs of control and treated mice
clearly suggest the development of edema. In inflamma-
tory setting the inducible Cox-2 are detected in various
reports [37]. We showed it also through ELISA and immu-
nohistochemistry. In our consideration lung cells switch
on such signaling which helps to proliferate against the
stressed environment. It is already suggested by various
scientists that IL-6-activated Janus kinase which leads to
the activation of signal transducer and activator of tran-
scription (STAT) and Akt signaling cascades [38]. There
are supportive evidences that cadmium increases IL-6 pro-
duction [39] and Akt activation in cancer cell [40]. On the
other hand IL-6 induced ICAM-1 expression is mediated
via JAK/STAT signaling pathway in which STAT3 phos-
phorylation followed by its binding to IRE which are in
the promoter of cell cycle-related genes including
CyclinD1[41]. Constitutive activation of STAT3 signaling
contributes to oncogenesis by preventing apoptosis and
enhancing cell proliferation. Moreover, Cox-2 dependent
expression of IL-6 has been implicated in STAT3 activa-
tion and IL-6-dependent STAT3 activation has been
shown to increase angiogenesis in several cancers [42]. We
showed that though Ibuprofen reduces the expression
level of Cox-2 and IL-6, it could not prevent the expres-
sion of p-STAT3 and p-Akt and CyclinD1. So, due to
chronic exposure, cadmium promoted inflammation
independent of signaling towards. Our flowcytometric
results suggest cell cycle progression. It has been reported
that STAT3 activation up regulates target genes, such as
CyclinD1, that leads to cell cycle progression or preven-
tion of apoptosis and STAT3 inhibition results in the
down-regulation of CyclinD1[43]. As we know that
CyclinD1 is responsible for G0/G1/S and S/G2/M transi-
tion [30], therefore, we have correlated both of the back-
ground information to test the expression of CyclinD1
and found that CyclinD1 was upregulated in lung cell
after cadmium treatment, suggesting these pathways may
operate in our system. Collectively, these findings suggest
an important role for IL-6, Cox-2, STAT3, Akt and
CyclinD1 in cadmium induced inflammation and lung
cell proliferation.
Effect of Cadmium on CyclinD1 expression Figure 10
Effect of Cadmium on CyclinD1 expression. A, Expression of CyclinD1 was increased throughout all the experimental 
period. B, Bar graphs represent the quantitative densitometric value of the expressed protein. Data is representative of three 
comparable experiments indicate p < 0.05 with respect to the control. C, Immunoprecipitation showed the formation 
CyclinD1-Cdk4 complex, which is an indication of cell cycle progression.Journal of Inflammation 2009, 6:19 http://www.journal-inflammation.com/content/6/1/19
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We exposed mice to different concentrations of Cadmium
and found that low levels of Cadmium (5 mg) consist-
ently increased cell viability but higher levels of cadmium
inevitably led to cell death with same exposure. A similar
biphasic response has been reported previously by in vitro
study [25]. So it is the first in vivo study which might pro-
vide a mechanistic explanation for Cadmium-induced cell
proliferation independent of inflammation in normal
lung cells. Many of the observations described cells are
adapted when cadmium exposure continued for a longer
period [44]. Similar observations of chronic pulmonary
inflammation reported in cigarette smoke exposed mice
[45]. We proved that for the first time that cadmium expo-
sure promotes pulmonary inflammation but this may not
be the cause of lung cell proliferation.
Conclusion
These data provide a new insight into the relation between
chronic inflammation and cell proliferation in vivo.
Involvement of different inflammatory, signaling and cell
cycle regulatory molecules in cadmium induced mice lung
cell require further investigation. Our experimental model
have both limitations and advantages. However, one
major point should be taken into consideration before
comparing our results obtained in mice model with
human is that, though minute amount of cadmium
deposit in lung if administered intraperitoneally or
through contaminating food, it can still induces inflam-
mation and proliferation due to persistent presence in
lung cell but this two events may occur independently.
Further in vitro studies in progress to delineate the cross-
talk of inflammation and proliferation by cadmium.
Abbreviations
Cd: cadmium; Cox-2: Cyclooxygenase-2; STAT3: signal
transducer and activator of transcription factor 3; IL-6:
Interleukin-6; i.p: intraperitonial; ELISA: enzyme-linked
immunosorbent assay; SEM: scanning electron micros-
copy; MMP: matrix metalloproteinases; NSAID: non ster-
oidal anti-inflammatory drug.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
SK is the head player of designing all these experiments.
SS helped in histology, ELISA and immunohistochemis-
try. SC contributed by his analysis. SM and TK helped in
animal handling western blot. AB designed and super-
vised all the experiments. All authors read and approved
the final manuscript.
Acknowledgements
Authors want to thank to Dr. Palash Kr. Mandal (Medical College, Kolkata) 
and Dr. Sabasti Roy, (Thakurpukur cancer Hospital) for there guide in his-
topathology and immunohistochemical analysis. Authors are very much 
grateful to Dr. Srikanta Chakraborty and Prof. A. Bhattacharyya of Univer-
sity Burdwan, West Bengal, India, for their unconditional help during SEM 
(Scanning electron microscopy) analysis. This work was supported by 
grants from Department of Science and Technology, Govt. of India (SR/FT/
L-42/2006). Also we like to thank Department of Biotechnology, Govt. of 
India (BT/PR9779/GBD 27/67/2007) and Indian Council of Medical 
Research, Govt. of India (Immuno/18/11/21/ECD-1-2002) for equipment 
support.
References
1. Jarup L, Berglund M, Elinder CG, Nordberg G, Vahter M: Health
effects ofcadmium exposure: a review of the literature and a
risk estimate.  Scand J Work Environ Health 1998, 24:1-51.
2. Jin T, Lu J, Nordberg M: Toxicokinetics and biochemistry of cad-
mium with special emphasis on the role of metallothionein.
Neurotoxicology 1998, 19:529-535.
3. Rikans LE, Yamano T: Mechanisms of cadmium-mediated acute
hepatotoxicity.  J Biochem Mol Toxicol 2000, 14:110-117.
4. Thevenod F: Nephrotoxicity and the proximal tubule. insights
from cadmium.  Nephron Physiol 2003, 93(4):p87-p93.
5. Nandi M, Slone D, Jick H, Shapiro S, Lewis GP: Cadmium content
of cigarettes.  Lancet 1969, 2:329-330.
6. Schwartz GG, Reis IM: Is cadmium a cause of human pancreatic
cancer?  Cancer Epidemiol Biomarkers Prev 2000, 9:139-145.
7. Othumpangat S, Kashon M, Joseph P: Eukaryotic translation initi-
ation factor 4E is a cellular target for toxicity and death due
to exposure to cadmium chloride.  J Biol Chem 2005,
280:25162-25169.
8. Badisa VL, Latinwo LM, Odewumi CO, Ikediobi CO, Badisa RB,
Brooks-Walter A, Lambert AT, Nwoga J: Cytotoxicity and stress
gene microarray analysis in cadmium-exposed CRL-1439
normal rat liver cells.  Int J Mol Med 2008, 22:213-219.
9. Waalkes MP, Perantoni A, Rehm S: Tissue susceptibility factors in
cadmium carcinogenesis. Correlation between cadmium-
induction of prostatic tumors in rats and an apparent defi-
ciency of metallothionein.  Biol Trace Elem Res 1989, 21:483-490.
10. Waalkes MP, Anver M, Diwan BA: Carcinogenic effects of cad-
mium in thenoble (NBL/Cr) rat: induction of pituitary, tes-
ticular, and injection site tumors and intraepithelial
proliferative lesions of the dorsolateral prostate.  Toxicol Sci
1999, 52:154-161.
11. Oh SH, Lee BH, Lim SC: Cadmium induces apoptotic cell death
in WI 38 cells via caspase- dependent Bid cleavage and cal-
pain-mediated mitochondrial Bax cleavage by Bcl-2-inde-
pendent pathway.  Biochemical Pharmacology 2004, 68:1845-1855.
12. Bell RR, Nonavinakere VK, Soliman MR: Intratracheal exposure of
the guinea pig lung to cadmium and/or selenium: a histolog-
ical evaluation.  Toxicol Lett 2000, 114:101-109.
13. Kataranovski M, Kataranovski D, Savic D, Jovcic G, Bogdanovic Z,
Jovanovic T: Granulocyte and plasma cytokine activity in
acute cadmium intoxication in rats.  Physiol Res 1998,
47:453-461.
14. Eneman JD, Potts RJ, Osier M: Suppressed oxidant-induced
apoptosis in cadmium adapted alveolar epithelial cells and
its potential involvement in cadmium carcinogenesis.  Toxicol-
ogy 2000, 147:215-228.
15. Harstad EB, Klaassen CD: Tumor necrosis factor-alpha-null
mice are not resistant to cadmium chloride-induced hepato-
toxicity.  Toxicol Appl Pharmacol 2002, 179:155-162.
16. Klaassen CD, Liu J, Choudhuri S: Metallothionein: An intracellu-
lar protein to protect against cadmium toxicity.  Annu Rev
Pharmacol Toxicol 1999, 39:267-294.
17. Kuester RK, Waalkes MP, Goering PL, Fisher BL, McCuskey RS, Sipes
IG:  Differential hepatotoxicity induced by cadmium in
Fischer 344 and Sprague-Dawley rats.  Toxicol Sci 2002,
65:151-159.
18. Bihl M, Tamm M, Nauck M, Wieland H, Perruchoud AP, Roth M: Pro-
liferation of human non-small-cell lung cancer cell lines: role
of interleukin-6.  Am J Respir Cell Mol Biol 1998, 19:606-612.
19. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A:
Expression of cyclooxygenase-2 in human lung carcinoma.
Cancer Res 1998, 58:4997-5001.
20. Jee SH, Shen SC, Chiu HC, Tsai WL, Kuo ML: Overexpression of
interleukin-6 in human basal cell carcinoma cell linesPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Inflammation 2009, 6:19 http://www.journal-inflammation.com/content/6/1/19
Page 15 of 15
(page number not for citation purposes)
increases anti-apoptotic activity and tumorigenic potency.
Oncogene 2001, 20:198-208.
21. Khuri FR, Wu H, Lee JJ, Kemp BL, Lotan R, Lippman SM, Feng L, Hong
WK, Xu XC: Cyclooxygenase-2 overexpression is a marker of
poor prognosis in stage I non-smallcell lung cancer.  Clin Can-
cer Res 2001, 7:861-867.
22. Sinibaldi D, Wharton W, Turkson J, Bowman T, Pledger WJ, Jove R:
Induction of p21WAF1/CIP1 and cyclin D1 expression by the
Src oncoprotein in mouse fibroblasts: role of activated
STAT3 signaling.  Oncogene 2000, 19:5419-5427.
23. Achanzar WE, Diwan BA, Liu J, Quader ST, Webber MM, Waalkes
MP: Cadmium-induced malignant transformation of human
prostate epithelial cells.  Cancer Res 2001, 61:455-458.
24. Nakamura K, Yasunaga Y, Ko D, Xu LL, Moul JW, Peehl DM: Cad-
mium-induced neoplastic transformation of human prostate
epithelial cells.  Int. J Oncol 2002, 20:543-547.
25. Achanzar WE, Achanzar KB, Lewis JG, Webber MM, Waalkes MP:
Cadmium induces c-myc, p53, and c-jun expression in nor-
mal human prostate epithelial cells as a prelude to apoptosis.
Toxicol Appl Pharmacol 2000, 164:291-300.
26. Smalinskiene A, Gaileviciûte R, Lesauskaite V, Sadauskiene I, Abdra-
khmanov O, Ivanov L: Effects of cadmium and zinc ions on
mitotic activity and protein synthesis in mouse liver.  Medicina
(Kaunas) 2005, 41:506-511.
27. Banerjee S, Maity P, Mukherjee S, Sil AK, Panda K, Chattopadhyay D,
Chatterjee IB: Black tea prevents cigarette smoke-induced
apoptosis and lung damage.  J Inflamm (Lond) 2007, 4:3.
28. Roomi MW, Monterrey JC, Kalinovsky T, Rath M, Niedzwiecki A:
Patterns of MMP-2 and MMP-9 expression in human cancer
cell lines.  Oncol Rep 2009, 21:1323-1333.
29. Atkinson JJ, Senior RM: Matrix metalloproteinase-9 in lung
remodelling.  Am J Respir Crit Care Med 2003, 28:12-24.
30. Cai FG, Xiao JS, Ye QF: Effects of ischemic preconditioning on
cyclinD1 expression during early ischemic reperfusion in
rats.  World J Gastroenterol.  2006, 12(18):2936-2940.
31. Folkman J: Role of angiogenesis in tumor growth and metasta-
sis.  Semin Oncol 2002, 29:15-18.
32. Rakoff-Nahoum S: Why Cancer and Inflammation?  Yale J Biol
Med 2006, 79:123-130.
33. Bakshi S, Zhang X, Godoy-Tundidor S, Robert Yuk Sing Cheng RY,
Maureen A, Sartor MA, Medvedovic M, Ho1 SM: Transcriptome
Analyses in Normal Prostate Epithelial Cells Exposed to
Low-Dose Cadmium: Oncogenic and Immunomodulations
Involving the Action of Tumor Necrosis Factor.  Environmental
Health Perspectives 2008, 116:769-776.
34. Lau AT, Zhang J, Chiu JF: Acquired tolerance in cadmium
adapted lung epithelial cells: Roles of the c-jun N terminal
kinase signaling pathway, and basal level of metallothionein.
Toxicol Appl Pharmacol 2006, 215:1-8.
35. Harris RE, Beebe-Donk J, Alshafie GA: Cancer chemoprevention
by cyclooxygenase 2 (COX-2) blockade: results of case con-
trol studies.  Subcell Biochem 2007, 42:193-212.
36. Tassone P, Neri P, Burger R, Savino R, Shammas M, Catley L, Podar
K, Chauhan D, Masciari S, Gozzini A, Tagliaferri P, Venuta S, Munshi
NC, Anderson KC: Combination therapy with interleukin-6
receptor super antagonist Sant7 and dexamethasone
induces antitumor effects in a novel SCID-hu in vivo models
of human multiple myeoloma.  Clin Cancer Res 2005,
11:4251-4258.
37. Peppelenbosch MP, Tertoolen LG, Hage WJ: Epidermal growth
factor-induced actin remodeling is regulated by 5 lipoxygen-
ase and cyclooxygenase products.  Cell 1993, 74:565-575.
38. Cabrespine A, Bay JO, Verrelle P, Morel L: Interleukin-
6implication in prostate cancer.  Bull Cancer 2007, 94:29-34.
39. Kayama F, Yoshida TY, Elwell MR, Luster MI: Cadmium-induced
renal damage and proinflammatory cytokines: possible role
of IL-6 in tubular epithelial cell regeneration.  Toxicol Appl Phar-
macol 1995, 134:26-34.
40. Brama M, Gnessi L, Basciani S, Cerulli N, Politi L, Spera G, Mariani S,
Cherubin S, d'Abusco AS, Scandurra R, Migliaccio S: Cadmium
induces mitogenic signaling in breast cancer cell by an ERal-
pha-dependent mechanism.  Mol Cell Endocrinol 2007,
264:102-108.
41. Chen SC, Chang YL, Wang DL, Cheng JJ: Herbal remedy mag-
nolol suppresses IL-6-induced STAT3 activation and gene
expression in endothelial cells.  Br J Pharmacol 2006,
148:226-232.
42. Dalwadi H, Krysan K, Heuze-Vourc'h N, Dohadwala M, Elashoff D,
Sherven Sharma S, Cacalano N, Lichtenstein A, Dubinett S: Cycloox-
ygenase-2-dependent activation of signal transducer and
activator of transcription 3 by interleukin-6 in non-small cell
lung cancer.  Clin Cancer Res 2005, 11:7674-7682.
43. Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma
K, Tomita K, Komiyama S, Weinstein IB: Constitutive activationof
signal transducers and activators of transcription 3 corre-
lates with cyclin D1 overexpression and may provide a novel
prognostic marker in head and neck squamous cell carci-
noma.  Cancer Res.  2002, 62(12):3351-3355.
44. Waisberg M, Joseph P, Hale B, Beyersmann D: Molecular and cel-
lular mechanisms of cadmium carcinogenesis.  Toxicology 2003,
192:95-117.
45. Seagrave J, Barr EB, March TH, Nikula KJ: Effects of cigarette
smoke exposure and cessation on inflammatory cells and
matrix metalloproteinase activity in mice.  Exp Lung Res 2004,
30:1-15.